Benzinga | Aug 6, 2021 07:22AM EDT

Intersect ENT Q2 Adj. EPS $(0.49) Misses $(0.43) Estimate, Sales $27.30M Miss $28.02M Estimate

Intersect ENT (NASDAQ:XENT) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.43) by 13.95 percent. This is a 24.62 percent increase over losses of $(0.65) per share from the same period last year. The company reported quarterly sales of $27.30 million which missed the analyst consensus estimate of $28.02 million by 2.57 percent. This is a 179.14 percent increase over sales of $9.78 million the same period last year.